BR112012013918A2 - inibidores de diacil glicerol acil transferase - Google Patents

inibidores de diacil glicerol acil transferase

Info

Publication number
BR112012013918A2
BR112012013918A2 BR112012013918A BR112012013918A BR112012013918A2 BR 112012013918 A2 BR112012013918 A2 BR 112012013918A2 BR 112012013918 A BR112012013918 A BR 112012013918A BR 112012013918 A BR112012013918 A BR 112012013918A BR 112012013918 A2 BR112012013918 A2 BR 112012013918A2
Authority
BR
Brazil
Prior art keywords
transferase inhibitors
acyl transferase
diacyl glycerol
glycerol acyl
diacyl
Prior art date
Application number
BR112012013918A
Other languages
English (en)
Portuguese (pt)
Inventor
Erik James Hembre
Emily Jane Canada
Jianliang Lu
John Mehnert Schaus
John Robert Rizzo
Macklin Brian Arnold
Qing Shi
Thomas James Beauchamp
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR112012013918A2 publication Critical patent/BR112012013918A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112012013918A 2009-12-10 2010-12-07 inibidores de diacil glicerol acil transferase BR112012013918A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28531709P 2009-12-10 2009-12-10
PCT/US2010/059158 WO2011071840A1 (en) 2009-12-10 2010-12-07 Inhibitors of diacylglycerol acyltransferase

Publications (1)

Publication Number Publication Date
BR112012013918A2 true BR112012013918A2 (pt) 2016-04-26

Family

ID=43569741

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012013918A BR112012013918A2 (pt) 2009-12-10 2010-12-07 inibidores de diacil glicerol acil transferase

Country Status (14)

Country Link
US (1) US8299061B2 (enExample)
EP (1) EP2509981B1 (enExample)
JP (1) JP5631411B2 (enExample)
KR (1) KR101395428B1 (enExample)
CN (1) CN102666543B (enExample)
AR (1) AR079170A1 (enExample)
AU (1) AU2010328410B2 (enExample)
BR (1) BR112012013918A2 (enExample)
CA (1) CA2783684C (enExample)
EA (1) EA020128B1 (enExample)
ES (1) ES2509922T3 (enExample)
MX (1) MX2012006646A (enExample)
TW (1) TWI392680B (enExample)
WO (1) WO2011071840A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
US8841487B2 (en) 2010-07-16 2014-09-23 Abbvie Inc. Phosphine ligands for catalytic reactions
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
NZ705225A (en) 2010-07-16 2016-11-25 Abbvie Bahamas Ltd Process for preparing antiviral compounds
WO2015120610A1 (en) * 2014-02-14 2015-08-20 Eli Lilly And Company Gpr142 agonist compound
CN105153195B (zh) * 2015-09-01 2017-09-26 汤文建 一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
CA3142360C (en) * 2019-05-31 2023-11-14 Medshine Discovery Inc. Bicyclic compound as rip-1 kinase inhibitor and application thereof
TWI824259B (zh) * 2020-07-01 2023-12-01 美商雷傑製藥公司 Rip1k抑制劑

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847248A (en) * 1986-12-23 1989-07-11 Merck & Co., Inc. 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists
US4735941A (en) * 1986-12-23 1988-04-05 Merck & Co., Inc. 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents
EP0272866A1 (en) 1986-12-23 1988-06-29 Merck & Co. Inc. 1,4-Benzodiazepines with 5-membered heterocyclic rings
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them
EP0523846A3 (en) 1991-06-14 1993-03-17 Merck & Co. Inc. 1,4-benzodiazepines with 5-membered heterocyclic rings
US5679672A (en) * 1993-11-22 1997-10-21 Merck & Co., Inc. Benzodiazepines
DK0730581T3 (da) * 1993-11-22 2001-11-26 Merck & Co Inc 3-acylaminobezazepiner
US5439906A (en) * 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines
US5834464A (en) * 1994-11-18 1998-11-10 Merck & Co., Inc. Imidazolinobenzodiazepines
ZA9711537B (en) 1996-12-23 1998-06-25 Athena Neurosciences Inc Eli L Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting ß-amyloid peptide release and/or its synthesis by use of such compounds.
GB0012671D0 (en) * 2000-05-24 2000-07-19 Merck Sharp & Dohme Therapeutic agents
EP1784390A2 (en) * 2004-08-13 2007-05-16 Amgen Inc. Substituted benzofused heterocycles
JP2008540485A (ja) * 2005-05-10 2008-11-20 エフ．ホフマン−ラ ロシュ アーゲー ジアシルグリセロールアシルトランスフェラーゼ阻害剤
CA2615463A1 (en) 2005-07-29 2007-02-08 Merck & Co., Inc. Heterocyclic benzodiazepine cgrp receptor antagonists
US7569590B2 (en) * 2006-09-19 2009-08-04 Bristol-Myers Squibb Company Use of thianecarboxamides as dgat inhibitors
US8324241B2 (en) 2008-04-11 2012-12-04 Bristol-Myers Squibb Company Triazolo compounds useful as DGAT1 inhibitors
WO2009126861A2 (en) 2008-04-11 2009-10-15 Bristol-Myers Squibb Company Triazolopyridine compounds useful as dgat1 inhibitors
JP2010116364A (ja) * 2008-11-14 2010-05-27 Banyu Pharmaceut Co Ltd アゼピノン誘導体
US20110319396A1 (en) 2009-01-23 2011-12-29 Msd K.K. Benzodiazepin-2-on derivatives
AU2010216632A1 (en) 2009-02-17 2011-08-04 Msd K.K. 1,4-benzodiazepin-2-on derivatives

Also Published As

Publication number Publication date
AU2010328410A1 (en) 2012-07-26
JP2013513607A (ja) 2013-04-22
EA020128B1 (ru) 2014-08-29
AR079170A1 (es) 2011-12-28
CN102666543A (zh) 2012-09-12
CN102666543B (zh) 2014-12-24
MX2012006646A (es) 2012-06-25
US20110144091A1 (en) 2011-06-16
KR101395428B1 (ko) 2014-05-14
CA2783684A1 (en) 2011-06-16
AU2010328410B2 (en) 2014-02-06
TWI392680B (zh) 2013-04-11
TW201130844A (en) 2011-09-16
EP2509981A1 (en) 2012-10-17
EA201200868A1 (ru) 2012-12-28
WO2011071840A1 (en) 2011-06-16
ES2509922T3 (es) 2014-10-20
KR20120099457A (ko) 2012-09-10
US8299061B2 (en) 2012-10-30
EP2509981B1 (en) 2014-08-06
CA2783684C (en) 2014-02-25
JP5631411B2 (ja) 2014-11-26

Similar Documents

Publication Publication Date Title
JO3530B1 (ar) مركبات بيريدازين 1،4-ثنائية الإرتباط ونظائرها وطرق معالجة نقص smn وحالاته المرضية.
ECSP10010035A (es) Amidas heterocíclicas y sus métodos de uso
EA201692506A3 (ru) Ингибиторы репликации вирусов гриппа
BR112014026493A2 (pt) derivados de imidazotiadiazol como inibidores do receptor ativado por protease 4 (par4) para tratar a agregação de plaqueta
IN2012DN01233A (enExample)
EA201100503A1 (ru) Глюкозидные производные и их применения
DOP2011000279A (es) Derivados de benzofuranilo usados como inhibidores de glucoquinasa
EA201001847A1 (ru) Соединения и композиции, применяемые для лечения малярии
MX2009000884A (es) Derivados de piridizinona.
BR112015028452A2 (pt) agonistas do receptor somastatina subtipo 4 (sstr4)
BR112012012903A2 (pt) compostos de espiropiperidina
EA201100750A1 (ru) Замещенные диоксопиперидинилфталимидные производные
PH12018500061A1 (en) Oxysterols and methods of use thereof
DOP2011000102A (es) Compuestos heteroaromaticos espirociclicos fusionados para el tratamiento de infecciones bacterianas
UY33246A (es) Tienopirimidinas que contienen cicloalquilo para composiciones farmacéuticas
MX2012002759A (es) Compuestos quimicos.
MX2013007336A (es) Compuestos de bi-heteroarilo como inhibidores de vps34.
CR20110255A (es) Nuevos compuestos 578
MY167898A (en) Co-crystals and salts of ccr3-inhibitors
SG194463A1 (en) Glycoside derivatives and their uses for the treatment of diabetes
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы
GEP20135806B (en) Lactams as beta secretase inhibitors
EA201071180A1 (ru) Конденсированные циклические соединения и их применение
MX2013011926A (es) Derivados de glicosido y usos de los mismos.
EA201200868A1 (ru) Ингибиторы диацилглицеролацилтрансферазы

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]